🇺🇸 IL-12 in United States
20 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 20
Most-reported reactions
- Antibody Test Positive — 2 reports (10%)
- Areflexia — 2 reports (10%)
- Blood Immunoglobulin G Increased — 2 reports (10%)
- Brain Oedema — 2 reports (10%)
- Convulsion — 2 reports (10%)
- Depressed Level Of Consciousness — 2 reports (10%)
- Diplopia — 2 reports (10%)
- Electroencephalogram Abnormal — 2 reports (10%)
- Facial Paresis — 2 reports (10%)
- General Physical Health Deterioration — 2 reports (10%)
Frequently asked questions
Is IL-12 approved in United States?
IL-12 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for IL-12 in United States?
National Institute of Allergy and Infectious Diseases (NIAID) is the originator. The local marketing authorisation holder may differ — check the official source linked above.